<SEC-DOCUMENT>0001193125-22-136873.txt : 20220502
<SEC-HEADER>0001193125-22-136873.hdr.sgml : 20220502
<ACCEPTANCE-DATETIME>20220502163819
ACCESSION NUMBER:		0001193125-22-136873
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220502
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220502
DATE AS OF CHANGE:		20220502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cabaletta Bio, Inc.
		CENTRAL INDEX KEY:			0001759138
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39103
		FILM NUMBER:		22882593

	BUSINESS ADDRESS:	
		STREET 1:		2929 ARCH STREET
		STREET 2:		SUITE 600
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		(267) 759-3100

	MAIL ADDRESS:	
		STREET 1:		2929 ARCH STREET
		STREET 2:		SUITE 600
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d232899d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:caba="http://www.cabalettabio.com/20220502" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-05-02_to_2022-05-02">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-05-02_to_2022-05-02">0001759138</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="caba-20220502.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-05-02_to_2022-05-02"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001759138</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-05-02</xbrli:startDate> <xbrli:endDate>2022-05-02</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-05-02_to_2022-05-02">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt:datemonthdayyearen">May&#160;2, 2022</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-05-02_to_2022-05-02">CABALETTA BIO, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-05-02_to_2022-05-02">001-39103</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-05-02_to_2022-05-02">82-1685768</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br />of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br />Identification No.)</span></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-05-02_to_2022-05-02">2929 Arch Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-05-02_to_2022-05-02">Suite 600</ix:nonNumeric>,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-05-02_to_2022-05-02">Philadelphia</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-05-02_to_2022-05-02">PA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-05-02_to_2022-05-02">19104</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Zip Code)</p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-05-02_to_2022-05-02">(267)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-05-02_to_2022-05-02">759-3100</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of&#160;Each&#160;Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;Each&#160;Exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on&#160;Which Registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-05-02_to_2022-05-02">Common Stock, par value $0.00001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-05-02_to_2022-05-02">CABA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2022-05-02_to_2022-05-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;2, 2022, Cabaletta Bio, Inc. issued a press release announcing that data from its two lead programs, DSG3-CAART and MuSK-CAART, will be presented at multiple upcoming scientific meetings in May 2022. A copy of the full text of the press release referenced above is furnished as Exhibit 99.1 to this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K&#160;and&#160;is</span> incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in Item 7.01 of this Current Report on Form <span style="white-space:nowrap">8-K,</span> including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:94%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d232899dex991.htm">Press Release issued by the registrant on May 2, 2022, furnished herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL Document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">CABALETTA&#160;BIO,&#160;INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;Date: May&#160;2, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven Nichtberger</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Steven Nichtberger, M.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d232899dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g232899dsp1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cabaletta Bio to Present DSG3-CAART Clinical Data and </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MuSK-CAART Preclinical Data at Upcoming Scientific </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Meetings in May </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PHILADELPHIA,
May</B><B></B><B>&nbsp;2, 2022</B> &#151; Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients with autoimmune diseases, today announced that data
from its two lead programs, DSG3-CAART and MuSK-CAART, will be presented at multiple upcoming scientific meetings in May 2022. The DSG3-CAART presentations will include Phase 1 clinical data from the ongoing DesCAARTes<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> trial. The MuSK-CAART presentations will contain preclinical safety and activity studies to support potential clinical development of precision engineered
<FONT STYLE="white-space:nowrap">T-cell</FONT> therapy for MuSK-associated myasthenia gravis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Desmoglein 3 chimeric autoantibody receptor T (DSG3-CAART)
cells are currently being evaluated in the Phase 1 DesCAARTes<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> trial as a potential treatment for patients with mucosal pemphigus vulgaris (mPV). Details of the presentations are as follows:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>American Society of Gene&nbsp;&amp; Cell Therapy 25th Annual Meeting at Walter E. Washington Convention Center in Washington, D.C. from May <FONT
STYLE="white-space:nowrap">16-19,</FONT> 2022 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Title:</B> A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus
Vulgaris (mPV) Patients: Early Cohort Data </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Abstract Number:</B> 793 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Poster Number:</B> Tu-298 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date and Time:</B> Tuesday,
May&nbsp;17, 2022, 5:30 p.m. &#150; 6:30 p.m. ET </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presenter: </B>David J. Chang, M.D., Chief Medical Officer at Cabaletta Bio </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Title:</B> Characterization of DSG3-CAART Cells Prior to&nbsp;&amp; Following Adoptive Transfer in Mucosal Pemphigus Vulgaris </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Abstract Number:</B> 698 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Poster Number:</B> Tu-203 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date and Time:</B> Tuesday, May&nbsp;17, 2022, 5:30 p.m. &#150; 6:30 p.m. ET </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presenter:</B> Samik Basu, M.D., Chief Scientific Officer at Cabaletta Bio </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to these poster presentations, Aimee Payne, M.D., Ph.D., a Professor of Dermatology at the Perelman School of Medicine at the University of
Pennsylvania, <FONT STYLE="white-space:nowrap">co-chair</FONT> of the Cabaletta Bio Scientific Advisory Board and <FONT STYLE="white-space:nowrap">co-founder</FONT> at Cabaletta Bio, will deliver a presentation titled &#147;Genetically Engineered
CAAR T Cell Therapies for B cell-mediated Autoimmune Diseases&#148; on Wednesday, May&nbsp;18, 2022, at 9:12 a.m. ET. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Society For Investigative
Dermatology 2022 Annual Meeting at Oregon Convention Center in Portland, OR from May <FONT STYLE="white-space:nowrap">18-21,</FONT> 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Title:</B> A phase 1 trial of DSG3-CAART cells in mucosal-dominant pemphigus vulgaris (mPV) patients: Preliminary data </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Abstract Number:</B> LB952 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date and Time:</B> Friday,
May&nbsp;20, 2022, 4:30 p.m. &#150; 6:30 p.m. PT </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presenter: </B>Aimee Payne, M.D., Ph.D., a Professor of Dermatology at the Perelman School of Medicine at
the University of Pennsylvania, <FONT STYLE="white-space:nowrap">co-chair</FONT> of the Cabaletta Bio Scientific Advisory Board and <FONT STYLE="white-space:nowrap">co-founder</FONT> at Cabaletta Bio </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cabaletta plans to begin a clinical study in 2022 to evaluate muscle-specific kinase (MuSK) chimeric autoantibody receptor T (MuSK-CAART) cells as a potential
treatment for patients with MuSK-associated myasthenia gravis. Details of the presentations on the MuSK-CAART program are as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>American
Association of Immunologists IMMUNOLOGY2022<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> at Oregon Convention Center in Portland, OR from May <FONT STYLE="white-space:nowrap">6-10,</FONT> 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Title:</B> Adoptive immunotherapy for MuSK subtype myasthenia gravis </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Session Title:</B> NextGen Transformative Immunologic Therapies for Human Disease </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date and Time:</B> Sunday, May&nbsp;8, 2022, 8:00 a.m. &#150; 10:00 a.m. PT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Location: </B>Room<B> </B><FONT STYLE="white-space:nowrap">A107-109</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presenter:</B> Samik Basu, M.D., Chief Scientific Officer at Cabaletta Bio </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14th MGFA International Conference On Myasthenia And Related Disorders at Hyatt Regency Hotel in Miami, FL from May
<FONT STYLE="white-space:nowrap">10-12,</FONT> 2022 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Title:</B> Preclinical Safety and Activity Studies Supporting Precision Engineered <FONT
STYLE="white-space:nowrap">T-Cell</FONT> Therapy for MuSK Myasthenia Gravis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date and Time:</B> Tuesday, May&nbsp;10, 2022, 6:00 p.m. &#150; 7:30 p.m.
ET and Wednesday, May&nbsp;11, 2022, 6:00 p.m. &#150; 7:30 p.m. ET </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Location: </B>Regency Ballroom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presenter:</B> Jinmin Lee, Ph.D., Associate Principal Scientist at Cabaletta Bio </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to this presentation, Dr.&nbsp;Aimee Payne will deliver a presentation titled &#147;Precision Cellular Immunotherapy for Myasthenia Gravis&#148;
on Tuesday, May&nbsp;10, 2022, at 11:30 a.m. ET. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>American Society of Gene&nbsp;&amp; Cell Therapy 25th Annual Meeting at Walter E. Washington
Convention Center in Washington, D.C. from May <FONT STYLE="white-space:nowrap">16-19,</FONT> 2022 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Title:</B> Muscle-Specific Tyrosine Kinase
Chimeric Autoantibody Receptor T Cells (MuSK-CAART): A Precision Cellular Immunotherapy for Antigen-Specific B Cell Depletion in MuSK Myasthenia Gravis </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Session Title:</B> Musculo-skeletal Diseases </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Abstract
Number:</B> 29 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date and Time:</B> Monday, May&nbsp;16, 2022, 10:15 a.m. &#150; 10:30 a.m. ET </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Location: </B>Salon G </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presenter: </B>Sangwook Oh, Ph.D., a
Senior Research Investigator in Dr.&nbsp;Payne&#146;s lab at the University of Pennsylvania </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information, including the <U>ASGCT abstracts</U>
as submitted in February 2022, can be found on the respective scientific conferences&#146; websites. Presentation materials will be made available under the Posters&nbsp;&amp; Publications section of the Company&#146;s website shortly after the
event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CAAR T Cell Therapy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chimeric AutoAntibody Receptor (CAAR) T cells are designed to selectively bind and eliminate only disease-causing B cells, while sparing the normal B cells
that are essential for human health. CAAR T cells are based on the chimeric antigen receptor (CAR) T cell technology. While CAR T cells typically contain a CD <FONT STYLE="white-space:nowrap">19-targeting</FONT> molecule, CAAR T cells express an
autoantibody-targeted antigen on their surface. The <FONT STYLE="white-space:nowrap">co-stimulatory</FONT> domain and the signaling domain of both a CAR T cell and a CAAR T cell carry out the same activation and cytotoxic functions. Thus,
Cabaletta&#146;s CAARs are designed to direct the patient&#146;s T cells to kill only the pathogenic cells that express disease-causing autoantibodies on their surface, potentially leading to complete and durable remission of disease while sparing
all other B cell populations that provide beneficial immunity from infection. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Cabaletta Bio </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the
potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> platform, in combination with Cabaletta Bio&#146;s proprietary
technology, has advanced a growing pipeline that currently includes potential treatments for patients with mucosal pemphigus vulgaris, MuSK-associated myasthenia gravis, PLA2R-associated membranous nephropathy, mucocutaneous pemphigus vulgaris and
hemophilia A with FVIII alloantibodies. Cabaletta Bio&#146;s headquarters are located in Philadelphia, PA. For more information, visit<U>&nbsp;www.cabalettabio.com</U> and follow us on LinkedIn. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>University of Pennsylvania Financial Disclosure </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>Dr.&nbsp;Payne is a Penn faculty member, scientific collaborator, key advisor, and <FONT STYLE="white-space:nowrap">co-founder</FONT> of Cabaletta Bio.
As such, she holds an equity stake in the Company, her laboratory at Penn receives sponsored research funding from Cabaletta Bio, and as an inventor of the licensed technology she may receive additional future financial benefits under licenses
granted by Penn to Cabaletta Bio. The University of Pennsylvania may also receive future financial benefit under licenses it has granted to Cabaletta Bio. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
&#147;forward-looking statements&#148; of Cabaletta Bio within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including without limitation, express or implied statements regarding expectations regarding:
Cabaletta&#146;s ability to grow its autoimmune-focused pipeline; the progress and results of its DesCAARTes<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Phase 1 trial, including Cabaletta&#146;s ability to enroll the requisite number
of patients, dose each dosing cohort in the intended manner, and progress the trial; the expected significance around the clinical data updates to be provided at the scientific meetings described herein and the expected timing and significance
around additional clinical data updates from the DesCAARTes<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> trial at additional scientific meetings throughout 2022 and 2023; the expectation that Cabaletta may improve outcomes for patients
suffering from mPV; expectations regarding the intended incentives conferred by Fast Track Designation for MuSK-CAART to improve activities of daily living and muscle strength in patients with MuSK antibody-positive myasthenia gravis; the
expectation that Cabaletta Bio may improve outcomes for patients suffering from MuSK MG; plans to initiate patient dosing in an open-label Phase 1 clinical trial to evaluate MuSK-CAART safety and tolerability in MuSK MG patients in 2022;
Cabaletta&#146;s ability to enroll the requisite number of patients, dose each dosing cohort in the intended manner, and progress the MusCAARTes<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> trial; the ability of MuSK-CAART to target B
cells that differentiate into antibody secreting cells, which produce autoantibodies against muscle-specific kinase; the expected significance around </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the preclinical data updates to be provided at the scientific meetings described herein; Cabaletta&#146;s plans to advance development of its preclinical pipeline; presentation of additional data
at upcoming scientific conferences, and other preclinical data; expectations regarding the design, implementation, timing and success of its current and planned clinical trials and the successful completion of nonclinical studies; planned potential
timing and advancement of its preclinical studies and clinical trials and related regulatory submissions; ability to optimize the impact of its collaborations on its development programs; the impact of
<FONT STYLE="white-space:nowrap">COVID-19</FONT> on the timing, progress, interpretability of data, and results of ongoing or planned preclinical and clinical trials; statements regarding the timing of regulatory filings regarding its development
programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any forward-looking statements in this press release are based on management&#146;s current expectations and beliefs of future events, and are
subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to:
the risk that signs of biologic activity may not inform long-term results; Cabaletta&#146;s ability to demonstrate sufficient evidence of safety, efficacy and tolerability in its preclinical and clinical trials of DSG3-CAART and MuSK-CAART; risks
related to clinical trial site activation or enrollment rates that are lower than expected; risks related to unexpected safety or efficacy data observed during clinical studies; risks related to the impact of public health epidemics, such as the
ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, affecting countries or regions in which we have operations or do business; risks related to Cabaletta&#146;s ability to protect and maintain its intellectual property position;
uncertainties related to the initiation and conduct of studies and other development requirements for its product candidates; and the risk that the initial or interim results of preclinical studies or clinical studies will not be predictive of
future results in connection with future studies. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause Cabaletta&#146;s actual results to differ from those contained in the
forward-looking statements, see the section entitled &#147;Risk Factors&#148; in Cabaletta&#146;s most recent annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> as well as discussions of potential risks, uncertainties, and other
important factors in Cabaletta&#146;s other filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Cabaletta undertakes no duty to update this information unless required by
law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anup Marda </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>investors@cabalettabio.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sarah McCabe </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stern Investor Relations, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-362-1200</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>sarah.mccabe@sternir.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>caba-20220502.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 5/3/2022 12:35:50 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:caba="http://www.cabalettabio.com/20220502"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cabalettabio.com/20220502"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="caba-20220502_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="caba-20220502_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>caba-20220502_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 5/3/2022 12:35:50 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>caba-20220502_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 5/3/2022 12:35:50 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="caba-20220502.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g232899dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g232899dsp1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MBUR_FO+H4]3U6PT>QN=1U.ZM[&QLH)+F[NKJ:.""V@A0O+-/+(0D42*,EF;
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M+Y=M%]C?S655)$8;3W#%E()=1P2,U75J<=+<J)RBK"I6Q<(M1<F[=]&_RO\
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M^?"/XT>)_C)^SE_PCOB73_'(5_%7@3Q#>K8$W6!NDM);BY@A(+H&$@F5T9@
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C 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140423494730216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001759138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CABALETTA BIO, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-1685768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2929 Arch Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">759-3100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CABA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d232899d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="caba-20220502.xsd" xlink:type="simple"/>
    <context id="duration_2022-05-02_to_2022-05-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001759138</identifier>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-05-02_to_2022-05-02">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-05-02_to_2022-05-02"
      id="Hidden_dei_EntityCentralIndexKey">0001759138</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-05-02_to_2022-05-02">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-05-02_to_2022-05-02">2022-05-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-05-02_to_2022-05-02">CABALETTA BIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-05-02_to_2022-05-02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-05-02_to_2022-05-02">001-39103</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-05-02_to_2022-05-02">82-1685768</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-05-02_to_2022-05-02">2929 Arch Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-05-02_to_2022-05-02">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-05-02_to_2022-05-02">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-05-02_to_2022-05-02">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-05-02_to_2022-05-02">19104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-05-02_to_2022-05-02">(267)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-05-02_to_2022-05-02">759-3100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-05-02_to_2022-05-02">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-05-02_to_2022-05-02">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-05-02_to_2022-05-02">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-05-02_to_2022-05-02">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-05-02_to_2022-05-02">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-05-02_to_2022-05-02">CABA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-05-02_to_2022-05-02">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-05-02_to_2022-05-02">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2022-05-02_to_2022-05-02">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ R(2B5)>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #(A*)4'#AEZC\!
M   \ @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV["0 S\E=5^0!-0BU1$N)0^
MD*H6E8K[DG6(Q3XBKP,M7U\G452D7GKR>FR-9V87YTC'?8Q']>5=2(6NF9MY
MEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88
M!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3 QFU+BLX5
M>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)'0.M
M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND53 >
M"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R( DN
MR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ R(2B5"0>
MFZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#
M, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W
M;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9
MHIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJ
MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( ,B$
MHE1ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%
MKQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/
M$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4
MZ]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N
M6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC
M JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@A
MLO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_
M7G\!4$L! A0#%     @ R(2B5 =!36*!    L0   !               ( !
M     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #(A*)493%[^^X    K
M @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M    " #(A*)4F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE
M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,B$HE1.7V1C:@0  'H1   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " #(A*)4GZ ;\+$"  #B#   #0              @ &M#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( ,B$HE27BKL<P    !,"   +
M  "  8D/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,B$HE0<.&7J/P$  #P"
M   /              "  7(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" #(A*)4)!Z;HJT   #X 0  &@              @ '>$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #(A*)499!YDAD!  #/ P
M$P              @ '#$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"   -%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d232899d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d232899d8k.htm">d232899d8k.htm</File>
    <File>caba-20220502.xsd</File>
    <File>caba-20220502_lab.xml</File>
    <File>caba-20220502_pre.xml</File>
    <File>d232899dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d232899d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d232899d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "caba-20220502_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "caba-20220502_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "caba-20220502.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "caba",
   "nsuri": "http://www.cabalettabio.com/20220502",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d232899d8k.htm",
      "contextRef": "duration_2022-05-02_to_2022-05-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d232899d8k.htm",
      "contextRef": "duration_2022-05-02_to_2022-05-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cabalettabio.com//20220502/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-22-136873-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-136873-xbrl.zip
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MR!8N*?-90/T([HJ6W\ 5"_IP%D7P1:=)U:<DXH&$_5PUHNR_L?XRT]W#ZU<
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M, IF4Z9!V(E$&P.#:DM#D%4"50KSOF5[-NH&P-J+XV< M4%!_"; [^9T]0E
M4^-\_YC3Y__V=)# 37_.:V4<3O'[W/GLGV6S;B#J#^5&MPO.&MXOW\_K",A*
M ]Q\W 5,LQ82G*DXI.I8]PW;Z;<,:9.FW4#]4] D(6S"XWC%\ON1TI;6BN2.
MD*VWPFN"7."M$40B.*\ NR6<*6ZQ\3+*3;MWP_F.1S2@"67S3VK%+:@?V;)L
MRNP(Y!H3O"K"!>$J-21^'^6AT'>&MZV6R^0VZML-VUM!]'P0A47Z24C]=(RX
MN;^W7SC4*72$L84I?BC2!>M#JDAXJS)0K@-9(4@K.8/>MHDR\,]T@HK^E90K
M(MP'P*#S,L:@VJ!Y&/;B$4>B0KNMP<C*M3H?+3FJG9)&MAR7-R18J?74=CB:
M36D26=_CV,_K:FE398";CSLM:XQ:6(N:7!R4.J3R[FN:5OK=6=$T:-H-U*GP
M];/F=]MXQJV7X$^2.D+4W#HW''2!TR"$1&:N#)FT,Y4M-%I&TK9;G.OFQ298
M*+>DR<,,YMR.KY]&([PZ!N,ZNJ^'?2TM*N \S-!>W\9KJF7S&._O7<1$S-74
M_"[X.EFHQ<C29PT?Y*V0Z/0=OGI;_&"H^WM\-;)(K.=OC!6%(*L$>2FD]_A:
MM&%XDZ^Q%Y01V*B?'$Q2?3<Q>R*N(?^&_&[AKS;$Z^,0L*_01&9^ X]E\L<8
ML8!OR8")=AL7Y1W7:DO_=:%\%\W^QH[:\S]02P,$%     @ R(2B5 9D#K[=
M!   ""X  !4   !C86)A+3(P,C(P-3 R7W!R92YX;6S5FEV/XC84AN]7VO_@
M9F]:J2$D+&T'#;.BS$R%.E\"MJUZLS+) :PZ=F2; ?Y][1"W!,(LF=U6\5P,
MD/@]?L]YC(F=7'[8I!0]@Y"$L[X7MMH> A;SA+!%WUM)'\N8$ ])A5F"*6?0
M][8@O0]7;]]<?N/[Z/IV](!\M%0JD[T@6*_7K61.F.1TI71(V8IY&B#?M^V'
MTX_HMUUW/30&"E@"2K%4(-#/*T*37M2.HG88=EMAM*\3@$U E& %/=0-.H%I
MB,*HU^GVNFTTN$<W>1B&IB2%?2G/MH(LE@I]&W^'<M4U9PPHA2VZ)0RSF&"*
M)M;R]VC$XA8:4(K&1B:U3PGB&9)6$942]E?/_)L9]^CM&Z3_="&9S(_V/5..
MHAJ;F: M+A;:;KL36)&WK]D<B=:=7!)>7%P$^=ER>TFJ6NL.PN"/^[M)O(04
M^QJ"AA8?=*7=).H?];ZY;K [:=M+TI-YI#L>YZ4_(RUTLH7YY-MFOCGDAY'?
M"5L;F7A7ILM=506G,(8Y,J\?QZ-2GS&>80I*X1GA^;C*AT"[VXX"A3><\70;
M&%UPS>-5"DS9UP%+;I@B:CMB<R[2/!L/Y87M+07,^YX)[=MHQM.[L0[TJ4X@
MM<WTET.2-*/@H6 OITSH\<-4WOI.'R@)8*. )9#8,":!_S#KJQW=8@CSN%0%
M^RW.T4F(6PO^'"1 3(^A>6-*E"-[IS]\&G(]<0QF4@D<JW(9J!DS7-B#%,^
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MZX2XN<1.&+;8W-E&F7!*8J((6]SK'V-!C+7SF%4IFPNLRJVEY<YFRI, ,^1
M7RWE]T',O6CQ.)^?/RV^%*&Y]%YR75!\[\X>RD$V(RE7(+Z<944<9XA6>+=<
MW=E8F4"\,A;#:#8EBIY]*7FL:RZW8Z^6DSN[)U.!S1-SDVTZXV?_W!V(FDOH
MP*C%X\[^B!UB-YMXB=D"ZMQNK=8V%U:U7\O,M7V0FQ3$0H^]7P1?JZ6>WS/,
M:CXR=")$<PF^:-N"=&<KI$AGHV<1)HDQMWM\HR;%"GWC$59XMOS^A^V2R^"H
M+G?Z@'F >7?&_#./X^HC?P-02P,$%     @ R(2B5+@KX_AN#P  ;V4   X
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M3 7"7&K;WP6 NJ4\+Z3S$7J^O[O[ML/&B,E\Y=?S;YJ!2 @E&46EN"!T5%\
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M   1              "  0    !C86)A+3(P,C(P-3 R+GAS9%!+ 0(4 Q0
M   ( ,B$HE23NAA@J08  *5)   5              "  7 #  !C86)A+3(P
M,C(P-3 R7VQA8BYX;6Q02P$"% ,4    " #(A*)4!F0.OMT$   (+@  %0
M            @ %,"@  8V%B82TR,#(R,#4P,E]P<F4N>&UL4$L! A0#%
M  @ R(2B5+@KX_AN#P  ;V4   X              ( !7 \  &0R,S(X.3ED
M.&LN:'1M4$L! A0#%     @ R(2B5(].W=E"%   15$  !$
M ( !]AX  &0R,S(X.3ED97@Y.3$N:'1M4$L%!@     %  4 0 $  &<S
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
